check_circleStudy Completed
Hypertension
Bayer Identifier:
12827
ClinicalTrials.gov Identifier:
EudraCT Number:
Not Available
EU CT Number:
Not Available
Assessment of Compliance With Antihypertensive Telmisartan Therapy
Trial purpose
The purpose of this study is to asses the efficacy and safety of Telmisartan depending on the use of an electronic therapy monitoring device (HelpingHand) in a real life setting and to asses patients compliance to the therapy with Telmisartan in relation to use of electronic therapy monitoring device.
Key Participants Requirements
Sex
BothAge
18 YearsTrial summary
Enrollment Goal
3400Trial Dates
April 2007 - January 2010Phase
N/ACould I Receive a placebo
NoProducts
Kinzal/Pritor (Telmisartan, BAY68-9291)Accepts Healthy Volunteer
NoWhere to participate
Status | Institution | Location |
---|---|---|
Completed | Many Locations, Poland | |
Completed | Many Locations, Slovakia |
Primary Outcome
- Efficacy and safety of the treatment with telmisartan reported by the physician with regard to usage the HelpingHand devicedate_rangeTime Frame:At all four planned control visits. (Approx. interval between visits 3 months)enhanced_encryptionYesSafety Issue:
Secondary Outcome
- Compliance with the treatment calculated on the basis of by HelpingHand and patients questionnairesdate_rangeTime Frame:At all four planned control visits. (Approx. interval between visits 3 months)enhanced_encryptionYesSafety Issue:
Trial design
Trial Type
ObservationalIntervention Type
DrugTrial Purpose
N/AAllocation
N/ABlinding
N/AAssignment
N/ATrial Arms
N/A